Table 1 Characteristics of ovarian cancer patients, N = 12,835.
From: Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study
Ovarian cancer without VTE | Ovarian cancer less than 4 months after VTE | Ovarian cancer 4 months to 27 years after VTE | |
|---|---|---|---|
(N = 12,707) | (N = 50) | (N = 78) | |
Median age, years | 63 | 67 | 71 |
(25%–75% percentile) | (54–73) | (58–78) | (62–78) |
Age groups | |||
<50 years | 2,239 (18%) | 6 (12%) | 9 (12%) |
50–69 years | 6,328 (50%) | 22 (44%) | 28 (36%) |
70–89 years | 4,051 (32%) | 22 (44%) | 39 (50%) |
90+ years | 89 (1%) | 0 (0%) | 2 (3%) |
Year of diagnosis | |||
1980–84 | 2,538 (20%) | 10 (20%) | 4 (5%) |
1985–89 | 2,711 (21%) | 13 (26%) | 13 (17%) |
1990–94 | 2,671 (21%) | 7 (14%) | 20 (26%) |
1995–99 | 2,690 (21%) | 7 (14%) | 24 (31%) |
2000–03 | 2,097 (17%) | 13 (26%) | 17 (22%) |
Comorbidity a | |||
0 | 11,289 (89%) | 47 (94%) | 60 (77%) |
1–2 | 1,361 (11%) | 3 (6%) | 17 (22%) |
3+ | 57 (<1%) | 0 | 1 (1%) |